To be honest I was surprised to see they moved the share price up toward the end of the day. I think the company would not be presenting on Monday at the conference if they had any thoughts of having a problem with any of their trials. Once again they will be getting their name out in front of some very influential people. This is a rather small company run by some very interesting people. If you haven't done so look over the background of these people. Yes they have had set backs but that usually goes with the territory in their kind of business. I come from a large family background in medicine and can fill your head with all types of stories. I have heavily researched this company and own a significant number of shares in it at a nice low entry level.
News 
Market Data 
Discover 
